Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Repurchase of Common Stock

Arcus Biosciences Inc Repurchase of Common Stock Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Repurchase of Common Stock from 2018 to 2018.
  • Arcus Biosciences Inc Repurchase of Common Stock for the quarter ending September 09, 2018 was $0m
Other Cash Flow Metrics:
  • Arcus Biosciences Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -86.39% increase of 6m year over year
  • Arcus Biosciences Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-5m
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS Repurchase of Common Stock Data

09/2018$0m
06/2018$-1m